Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and in vitro and in vivo validation
BackgroundThe peroxiredoxin family, a crucial regulator of redox reactions, is strongly associated with various tumorigenesis. However, the role of peroxiredoxin4 (PRDX4) in colon adenocarcinoma (COAD) remains poorly understood.MethodsMulticenter databases, including GEPIA, HPA, UALCAN, cBioPortal,...
Main Authors: | He Zhou, Lifa Li, Jia Chen, Songlin Hou, Tong Zhou, Yongfu Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1136738/full |
Similar Items
-
Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: a large population-based analysis
by: Songlin Hou, et al.
Published: (2024-07-01) -
Molecular cloning, functional characterization, tissue expression and polymorphism analysis of buffalo PRDX6 gene
by: Lihua Qiu, et al.
Published: (2021-11-01) -
Voluntary Exercise-Mediated Protection in TNBS-Induced Rat Colitis: The Involvement of NETosis and Prdx Antioxidants
by: Nikoletta Almási, et al.
Published: (2023-07-01) -
Tumoral Malignancy Decreases Coupled with Higher ROS and Lipid Peroxidation in HCT116 Colon Cancer Cells upon Loss of PRDX6
by: Daniel J. Lagal, et al.
Published: (2024-07-01) -
Prognostic and biological function value of OSBPL3 in colorectal cancer analyzed by multi-omic data analysis
by: Chengxing Wang, et al.
Published: (2023-08-01)